IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy

Georgia Hatzivassiliou; Ira Miller; Jun Takizawa; Nallasivam Palanisamy; Pulivarthi H. Rao; Shinsuke Iida; Shinichi Tagawa; Masafumi Taniwaki; James Russo; Antonino Neri; Giorgio Cattoretti; Raphael Clynes; Cathy Mendelsohn; R. S K Chaganti; Riccardo Dalla-Favera

doi:10.1016/S1074-7613(01)00109-1

IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy

Georgia Hatzivassiliou, Ira Miller, Jun Takizawa, Nallasivam Palanisamy, Pulivarthi H. Rao, Shinsuke Iida, Shinichi Tagawa, Masafumi Taniwaki, James Russo, Antonino Neri, Giorgio Cattoretti, Raphael Clynes, Cathy Mendelsohn, R. S K Chaganti, Riccardo Dalla-Favera

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Article

Abstract

Abnormalities of chromosome 1q21 are common in B cell malignancies, but their target genes are largely unknown. By cloning the breakpoints of a (1;14) (q21;q32) chromosomal translocation in a myeloma cell line, we have identified two novel genes, IRTA1 and IRTA2, encoding cell surface receptors homologous to the Fc and inhibitory receptor families. Both genes are selectively expressed in mature B cells: IRTA1 in marginal zone B cells and IRTA2 in centrocytes, marginal zone B cells, and immunoblasts. As a result of the t(1;14), IRTA1 is fused to the immunoglobulin Cα domain to produce a chimeric IRTA1/Cα fusion protein. In tumor cell lines with 1q21 abnormalities, IRTA2 expression is deregulated. Thus, IRTA1 and IRTA2 are novel immunoreceptors implicated in B cell development and lymphomagenesis.

Original language	English
Pages (from-to)	277-289
Number of pages	13
Journal	Immunity
Volume	14
Issue number	3
DOIs	https://doi.org/10.1016/S1074-7613(01)00109-1
Publication status	Published - 2001

ASJC Scopus subject areas

Immunology and Allergy
Infectious Diseases
Immunology

Access to Document

10.1016/S1074-7613(01)00109-1

Fingerprint Dive into the research topics of 'IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy'. Together they form a unique fingerprint.

Cite this

Hatzivassiliou, G., Miller, I., Takizawa, J., Palanisamy, N., Rao, P. H., Iida, S., Tagawa, S., Taniwaki, M., Russo, J., Neri, A., Cattoretti, G., Clynes, R., Mendelsohn, C., Chaganti, R. S. K., & Dalla-Favera, R. (2001). IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity, 14(3), 277-289. https://doi.org/10.1016/S1074-7613(01)00109-1

IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. / Hatzivassiliou, Georgia; Miller, Ira; Takizawa, Jun; Palanisamy, Nallasivam; Rao, Pulivarthi H.; Iida, Shinsuke; Tagawa, Shinichi; Taniwaki, Masafumi; Russo, James; Neri, Antonino; Cattoretti, Giorgio; Clynes, Raphael; Mendelsohn, Cathy; Chaganti, R. S K; Dalla-Favera, Riccardo.

In: Immunity, Vol. 14, No. 3, 2001, p. 277-289.

Research output: Contribution to journal › Article

Hatzivassiliou, G, Miller, I, Takizawa, J, Palanisamy, N, Rao, PH, Iida, S, Tagawa, S, Taniwaki, M, Russo, J, Neri, A, Cattoretti, G, Clynes, R, Mendelsohn, C, Chaganti, RSK & Dalla-Favera, R 2001, 'IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy', Immunity, vol. 14, no. 3, pp. 277-289. https://doi.org/10.1016/S1074-7613(01)00109-1

Hatzivassiliou, Georgia ; Miller, Ira ; Takizawa, Jun ; Palanisamy, Nallasivam ; Rao, Pulivarthi H. ; Iida, Shinsuke ; Tagawa, Shinichi ; Taniwaki, Masafumi ; Russo, James ; Neri, Antonino ; Cattoretti, Giorgio ; Clynes, Raphael ; Mendelsohn, Cathy ; Chaganti, R. S K ; Dalla-Favera, Riccardo. / IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. In: Immunity. 2001 ; Vol. 14, No. 3. pp. 277-289.

@article{3e740b220dab48049594c656b8f71a98,

title = "IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy",

abstract = "Abnormalities of chromosome 1q21 are common in B cell malignancies, but their target genes are largely unknown. By cloning the breakpoints of a (1;14) (q21;q32) chromosomal translocation in a myeloma cell line, we have identified two novel genes, IRTA1 and IRTA2, encoding cell surface receptors homologous to the Fc and inhibitory receptor families. Both genes are selectively expressed in mature B cells: IRTA1 in marginal zone B cells and IRTA2 in centrocytes, marginal zone B cells, and immunoblasts. As a result of the t(1;14), IRTA1 is fused to the immunoglobulin Cα domain to produce a chimeric IRTA1/Cα fusion protein. In tumor cell lines with 1q21 abnormalities, IRTA2 expression is deregulated. Thus, IRTA1 and IRTA2 are novel immunoreceptors implicated in B cell development and lymphomagenesis.",

author = "Georgia Hatzivassiliou and Ira Miller and Jun Takizawa and Nallasivam Palanisamy and Rao, {Pulivarthi H.} and Shinsuke Iida and Shinichi Tagawa and Masafumi Taniwaki and James Russo and Antonino Neri and Giorgio Cattoretti and Raphael Clynes and Cathy Mendelsohn and Chaganti, {R. S K} and Riccardo Dalla-Favera",

year = "2001",

doi = "10.1016/S1074-7613(01)00109-1",

language = "English",

volume = "14",

pages = "277--289",

journal = "Immunity",

issn = "1074-7613",

publisher = "Cell Press",

number = "3",

}

TY - JOUR

T1 - IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy

AU - Hatzivassiliou, Georgia

AU - Miller, Ira

AU - Takizawa, Jun

AU - Palanisamy, Nallasivam

AU - Rao, Pulivarthi H.

AU - Iida, Shinsuke

AU - Tagawa, Shinichi

AU - Taniwaki, Masafumi

AU - Russo, James

AU - Neri, Antonino

AU - Cattoretti, Giorgio

AU - Clynes, Raphael

AU - Mendelsohn, Cathy

AU - Chaganti, R. S K

AU - Dalla-Favera, Riccardo

PY - 2001

Y1 - 2001

N2 - Abnormalities of chromosome 1q21 are common in B cell malignancies, but their target genes are largely unknown. By cloning the breakpoints of a (1;14) (q21;q32) chromosomal translocation in a myeloma cell line, we have identified two novel genes, IRTA1 and IRTA2, encoding cell surface receptors homologous to the Fc and inhibitory receptor families. Both genes are selectively expressed in mature B cells: IRTA1 in marginal zone B cells and IRTA2 in centrocytes, marginal zone B cells, and immunoblasts. As a result of the t(1;14), IRTA1 is fused to the immunoglobulin Cα domain to produce a chimeric IRTA1/Cα fusion protein. In tumor cell lines with 1q21 abnormalities, IRTA2 expression is deregulated. Thus, IRTA1 and IRTA2 are novel immunoreceptors implicated in B cell development and lymphomagenesis.

AB - Abnormalities of chromosome 1q21 are common in B cell malignancies, but their target genes are largely unknown. By cloning the breakpoints of a (1;14) (q21;q32) chromosomal translocation in a myeloma cell line, we have identified two novel genes, IRTA1 and IRTA2, encoding cell surface receptors homologous to the Fc and inhibitory receptor families. Both genes are selectively expressed in mature B cells: IRTA1 in marginal zone B cells and IRTA2 in centrocytes, marginal zone B cells, and immunoblasts. As a result of the t(1;14), IRTA1 is fused to the immunoglobulin Cα domain to produce a chimeric IRTA1/Cα fusion protein. In tumor cell lines with 1q21 abnormalities, IRTA2 expression is deregulated. Thus, IRTA1 and IRTA2 are novel immunoreceptors implicated in B cell development and lymphomagenesis.

UR - http://www.scopus.com/inward/record.url?scp=17744386928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17744386928&partnerID=8YFLogxK

U2 - 10.1016/S1074-7613(01)00109-1

DO - 10.1016/S1074-7613(01)00109-1

M3 - Article

C2 - 11290337

AN - SCOPUS:17744386928

VL - 14

SP - 277

EP - 289

JO - Immunity

JF - Immunity

SN - 1074-7613

IS - 3

ER -